Research & Innovation Services

AstraZeneca - University of Bath
Innovation Training Course

Course dates: 21, 22, 23 March 2016
Location: Alexandra House, Swindon


The University of Bath currently holds funding from the MRC Proximity to Discovery scheme to increase knowledge exchange between academia and industry.

To this aim the University is offering researchers within the MRC remit the opportunity in conjunction with research scientists from AstraZeneca to attend a jointly developed innovation course.

This course will provide training to academic staff and industry research scientists in how to better communicate their research ideas in the form of business or investment plans to leverage funding or investment.

The University of Bath has engaged the SETsquared partnership, the Number 1 university business incubator in Europe, to deliver this training based on its internationally recognised entrepreneurship programme.


The 3-day residential course will be based around business propositions for a number of hypothetical or commercially available technologies, treatments and active ingredients.
The training will be broken down into a series of sessions which will provide participants with a theoretical grounding in developing business propositions in conjunction with practical exercises.
To encourage industry-academia interaction AstraZeneca and Bath participants will form teams and work together to develop their business propositions. On Day 3, the teams will pitch their ideas to a panel of “investors” for feedback.

A course outline is available.


For the course to be successful the University of Bath are looking for 6-8 academic or research staff who feel they would benefit from this course.

Application to participate

If you would like to be considered for this course please contact Philip Brown, Research Commercialisation Manager, by the 18 December with a brief email stating how you and your research could benefit from you participating in this course. These will then be considered by Professor David Bird, the PI on the funding.

Closing date

18 December 2015